Until the advent of the successful CAPTAIN-trials with Cerebrolysin, one of the most important unmet needs in medicine has been the treatment of severe and moderate traumatic brain injury with evidence-based pharmacological agents.
Our speakers will present to you with innovative preclinical and clinical treatment concepts for severe TBI patients, innovative educational programs focusing on this highly complex medical problem and innovative biometric approaches solving the historical trial design failures in TBI trials.
Johannes C. Vester
Ignacio J. Previgliano
Johannes C. VesterHead Biometry & Clinical Research
IDV Data Analysis and Study Planning, Gauting, Germany
Helmut TrimmelHead of Anaesthesia, Emergency and General Intensive Care Medicine
Landesklinikum Wiener Neustadt, Austria
Ignacio J. PreviglianoHospital General de Agudos J. A. Fernández
Buenos Aires City – Argentina
Peter LacknerHead of Department of Neurology, Clinic Floridsdorf, Vienna, Austria